Skip to content

Published hearing · house

H.Hrg.118

THE ROLE OF PHARMACY BENEFITS MANAGERS IN PRESCRIPTION DRUG MARKETS PART III: TRANSPARENCY AND ACCOUNTABILITY

CHRG-118hhrg56324

Publication

2024-07-23 · GovInfo record 2024-10-31 · OTHERPART

No committee proceeding is explicitly associated with this publication.

Witness lines from the publication

  • David Joyner, President, CVS Caremark, Executive Vice President, CVS Health
  • Adam Kautzner, PharmD, President, Express Scripts and Evernorth Care Management
  • Patrick Conway, MD, MSc, CEO, Optum Rx